Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:603168'
s Days Inventory Range Over the Past 10 Years
Min: 85.42 Med: 115.65 Max: 206.48
Current: 140.98
During the past 13 years, Zhejiang Shapuaisi Pharmaceutical Co's highest Days Inventory was 206.48. The lowest was 85.42. And the median was 115.65.
SHSE:603168's Days Inventory is ranked better than 60.2% of 922
companies
in the Drug Manufacturers industry
Industry Median: 164.72
vs SHSE:603168: 140.98
Inventory Turnover measures how fast the company turns over its inventory within a year.
Zhejiang Shapuaisi Pharmaceutical Co's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.59.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zhejiang Shapuaisi Pharmaceutical Co's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.83.
Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Zhejiang Shapuaisi Pharmaceutical Co's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zhejiang Shapuaisi Pharmaceutical Co's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Zhejiang Shapuaisi Pharmaceutical Co Days Inventory Related Terms
Zhejiang Shapuaisi Pharmaceutical Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Shapuaisi Pharmaceutical Co Days Inventory Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Shapuaisi Pharmaceutical Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Shapuaisi Pharmaceutical Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zhejiang Shapuaisi Pharmaceutical Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Zhejiang Shapuaisi Pharmaceutical Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) has a Days Inventory of 154.62 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Zhejiang Shapuaisi Pharmaceutical Co and its competitors. This is 34% above median its historical median of 115.65. Over the past decade, Zhejiang Shapuaisi Pharmaceutical Co's Days Inventory has ranged from 85.42 to 206.48. According to the industry distribution chart, Zhejiang Shapuaisi Pharmaceutical Co ranks #367 out of 922 companies in the Drug Manufacturers industry, placing it in the top 39.8%.
Is Zhejiang Shapuaisi Pharmaceutical Co's Days Inventory too high?
Zhejiang Shapuaisi Pharmaceutical Co's current Days Inventory of 154.62 is 34% above median its 10-year median of 115.65. Over the past 10 years, this metric has ranged from a low of 85.42 to a high of 206.48. The Drug Manufacturers industry median Days Inventory is 164.72. Zhejiang Shapuaisi Pharmaceutical Co's value of 154.62 is 6.1% below this industry median. Based on the distribution chart, Zhejiang Shapuaisi Pharmaceutical Co ranks #367 out of 922 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Zhejiang Shapuaisi Pharmaceutical Co has a GF Score™ of 37/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Shapuaisi Pharmaceutical Co's Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Zhejiang Shapuaisi Pharmaceutical Co ranks #367 out of 922 companies for Days Inventory. This puts Zhejiang Shapuaisi Pharmaceutical Co in the upper half of its industry. The industry median Days Inventory is 164.72. Zhejiang Shapuaisi Pharmaceutical Co's value of 154.62 is 6.1% below this benchmark. Historically, Zhejiang Shapuaisi Pharmaceutical Co's own Days Inventory has ranged from 85.42 to 206.48 over the past decade. While the company's 10-year median is 115.65 vs. the industry median of 164.72, Zhejiang Shapuaisi Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.72, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Shapuaisi Pharmaceutical Co's current Days Inventory of 154.62 is 6.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Zhejiang Shapuaisi Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Shapuaisi Pharmaceutical Co's current Days Inventory is 154.62, which is 34% above median its own 10-year median of 115.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Shapuaisi Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥8.96, compared to a current price of ¥5.11 — trading 43% below its estimated fair value. The current Days Inventory is 154.62, which is 34% above median its 10-year median of 115.65 and 6.1% below the Drug Manufacturers industry median of 164.72. Zhejiang Shapuaisi Pharmaceutical Co's overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168), the current Days Inventory is 154.62 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) Overvalued in 2026?
Based on GuruFocus' analysis, Zhejiang Shapuaisi Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥5.11 is trading 43% below its estimated GF Value™ of ¥8.96.
GuruFocus considers Zhejiang Shapuaisi Pharmaceutical Co to be Significantly Undervalued.
Key valuation signals for SHSE:603168:
Days Inventory: 154.62 (34% above median its 10-year median of 115.65)
GF Value™: ¥8.96 vs. price of ¥5.11 (43% below fair value)
Industry Position: 6.1% below the Drug Manufacturers median (#367 of 922)
No single metric tells the full story. See the SHSE:603168 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhejiang Shapuaisi Pharmaceutical Co Business Description
Zhejiang Shapuaisi Pharmaceutical Co Ltd is a China based pharmaceutical company. It is engaged in drug research and development, production and operation. The product portfolio of the company includes oral solutions, eye drops, tablets, hard capsules, suppositories, granules, raw materials dosage forms such as medicines, rinsing agent and mixture, and others. The company operates pharmaceutical manufacturing companies, pharmaceutical sales company, pharmaceutical retail company and pharmaceutical research institute. The products offered by the company are sold in China and are also exported to the other countries.
37GF Score
Get the complete analysis for SHSE:603168
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603168 has been successfully added to your 
